• Pseudo-UTP for mRNA Synthesis

  2026-09-17

  Pseudo-UTP enables controlled pseudouridine incorporation during in vitro transcription, supporting RNA stability, translation optimization, and lower innate immune activation in research workflows. This practical guide connects nucleotide selection with template screening, LNP-compatible RNA production, assay design, and troubleshooting for mRNA vaccine and gene therapy studies.

• (S)-(+)-Methoprene: Juvenile Hormone Workflows

  2026-09-16

  Use (S)-(+)-Methoprene as a stage-controlled juvenile hormone analog to separate receptor activation from endogenous hormone biosynthesis. The workflow connects Met-dependent transcription, vitellogenesis, insect metamorphosis inhibition, and comparative receptor studies while emphasizing solvent control, developmental staging, and rescue experiments.

• From Sialylation Biology to Quantitative Biotin Detection

  2026-09-15

  Mechanistic research on ST3GAL1-dependent sialylation and Fusobacterium nucleatum adhesion shows why translational teams need sensitive, controlled readouts. This article explains how Streptavidin-FITC can convert biotinylated molecular interactions into reproducible fluorescence across imaging and flow cytometry workflows.

• Fucoidan and the Gut–Liver Axis in Chemotherapy

  2026-09-15

  Fucoidan is more than an anticancer polysaccharide: emerging evidence places this Sulfated α-L-Fucan at the intersection of intestinal barrier biology, hepatic inflammation, and chemotherapy safety. This article translates mechanistic findings into practical assay decisions while distinguishing tumor-cell effects from gut–liver protection.

• Resiniferatoxin (RTX): TRPV1 Research Workflows

  2026-09-14

  Resiniferatoxin (RTX) enables targeted studies of TRPV1-driven pain, neurogenic inflammation, and sensory-nerve desensitization. This practical guide connects calcium-imaging assays with osteoarthritis, neuropathic pain, postoperative pain, and translational research workflows while emphasizing exposure control and troubleshooting.

• CNO: From Chemogenetic Ligand to Circuit Strategy

  2026-09-14

  Clozapine N-oxide is more than a DREADD ligand: it is a framework for connecting receptor engineering, circuit causality, and translational neuroscience. This article uses recent PVN oxytocin–VTA findings to define rigorous experimental design, product handling, and strategic interpretation.

• How Dual-Action Inhibitors Reprogram p38α Dephosphorylation

  2026-09-13

  The reference preprint shows that selected kinase inhibitors can do more than occupy the p38α active site: they can stabilize an activation-loop conformation that accelerates dephosphorylation by the phosphatase WIP1. Biochemical and X-ray crystallographic data support a design principle in which kinase inhibition and phosphatase-mediated signal termination are combined, although the findings remain preclinical and should not be generalized to every p38α MAPK inhibitor.

• Lyso-Tracker Red for Live-Cell Lysosome Imaging

  2026-09-12

  Lyso-Tracker Red is a weakly basic fluorescent probe for lysosome labeling in live cells. Its red emission, live-cell compatibility, and acid-compartment retention support lysosomal distribution and morphology analysis, while the product is not intended for fixed-cell staining.

• Clozapine N-oxide for Precision Neural Circuit Studies

  2026-09-12

  Clozapine N-oxide enables reversible, receptor-selective control of defined neuronal populations, making it useful for causal circuit mapping rather than observational neuroscience alone. This guide translates heart-brain axis findings into practical DREADDs workflows, with formulation, assay design, and troubleshooting strategies for reproducible CNO experiments.

• Torin2 B1640 for Reliable Viability Assays

  2026-09-11

  This scenario-driven guide explains how Torin2 (SKU B1640) can improve interpretation of cell viability, proliferation, and cytotoxicity assays through defined potency, solvent handling, and orthogonal apoptosis controls. It connects mTOR-pathway experiments with current regulated-cell-death evidence while emphasizing practical reproducibility over unsupported assumptions.

• PD0325901: Linking MEK Signals to Chromatin State

  2026-09-11

  PD0325901 is a selective MEK inhibitor that can connect RAS/RAF/MEK/ERK pathway perturbation with modern single-molecule chromatin assays. This article explains how IDLI-based nucleosome analysis can refine interpretation of signaling, cell-cycle, and cancer research experiments without overstating causality.

• SLC25A1, H3K27ac, and Cisplatin Resistance in HNSCC

  2026-09-10

  A 2026 npj Precision Oncology study identifies SLC25A1 as a metabolic and epigenetic regulator of cisplatin resistance in head and neck squamous cell carcinoma. The work connects mitochondrial citrate transport, cytosolic acetyl-CoA, H3K27ac-dependent transcription, and cellular senescence, while positioning SLC25A1 inhibition as a strategy for experimental treatment of resistant disease.

• 5hmC Maps Rice Drought Response by Genomic Context

  2026-09-10

  Yan and colleagues provide the first single-base-resolution map of 5-hydroxymethylcytosine in rice and show that its abundance, genomic distribution, and transcriptional effects change during drought and rehydration. The study positions 5hmC as a context-dependent regulator that can support transcriptional flexibility while coexisting with 5-methylcytosine-mediated transposon silencing.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-09

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for probing glucocorticoid access, corticosterone metabolism, and gap junction communication in cell- and tissue-based workflows. It is best used as an exploratory mechanistic perturbation with solvent, viability, and pathway controls, not as a validated in vivo efficacy treatment or selective target-validation agent.

• Vorinostat for Epigenetic Oncology Workflows

  2026-09-09

  Build reproducible HDAC-inhibition experiments with Vorinostat, from fresh DMSO stocks and dose-response design to orthogonal apoptosis and chromatin readouts. Use it as a benchmark across lymphoma, neuroblastoma, and other cancer models while separating cytostasis from true cell death.

8670 records 1/578 page Next 12345 下5页 Last page